Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 13, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 510,900 ordinary shares
- Highest Price Paid: 393.00 pence per share
- Lowest Price Paid: 387.70 pence per share
- Volume Weighted Average Price: 391.44 pence per share
- Post-Transaction Share Capital: 9,119,128,372 ordinary shares
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of 510,900 shares purchased for cancellation. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed transaction. The text notes that a full breakdown of individual trades is available via the London Stock Exchange and the company's investor website.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the current total share capital of 9,119,128,372 shares against the company's latest capital structure disclosures.
- Review the full trade breakdown at the provided RNS link for detailed execution timing and pricing.
- Check if the share count reduction impacts any shareholder notification thresholds under the FCA's Disclosure Guidance and Transparency Rules.